Security
EVOK · Evoke Pharma Inc
EVOKNASDAQCommon stockHistorical · closed Dec 16, 2025CIK 1403708Updated Sep 27, 2026
EVOK price & chart
Historical security
This listing closed Dec 16, 2025. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 17,519,007Source | 8,979,697Source | 11,851,488Source | 10,573,162Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 13,596,600Source | 7,006,431Source | 9,843,699Source | 9,144,710Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | 1,023,813Source | — | — |
| Inventory, NetUSD | 445,081Source | 513,712Source | 289,378Source | 185,534Source |
| Assets, CurrentUSD | 17,237,897Source | 8,926,855Source | 11,722,414Source | 10,560,734Source |
| Operating Lease, Right-of-Use AssetUSD | 154,184Source | 52,842Source | 129,074Source | 12,428Source |
| Other Assets, NoncurrentUSD | 6,312Source | — | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 10,480,997Source | 8,441,323Source | 7,766,839Source | 7,018,068Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 149Source | 334Source | 334Source | 3,266Source |
| Retained Earnings (Accumulated Deficit)USD | -128,791,632Source | -119,758,130Source | -115,647,143Source | -107,423,013Source |
| Stockholders' Equity Attributable to ParentUSD | 7,038,010Source | 538,374Source | 4,084,649Source | 3,555,094Source |
| Additional Paid in Capital, Common StockUSD | 135,829,493Source | 120,296,170Source | 119,731,458Source | 110,974,841Source |
| Liabilities and EquityUSD | 17,519,007Source | 8,979,697Source | 11,851,488Source | 10,573,162Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 10,380,039Source | 8,441,323Source | 1,654,544Source | 1,405,773Source |
| Operating Lease, Liability, CurrentUSD | 59,533Source | 52,842Source | 129,074Source | 12,428Source |
| Operating Lease, Liability, NoncurrentUSD | 100,958Source | — | — | — |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 773,121Source | 1,128,109Source | 1,458,709Source | 1,878,954Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 1,747,302Source | 48,239Source | 329,639Source | 271,882Source |
| Increase (Decrease) in InventoriesUSD | -32,839Source | 192,462Source | 103,843Source | -20,946Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -5,458,742Source | -4,984,977Source | -6,595,987Source | -12,352,944Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 14,315,916Source | -119,296Source | 7,294,976Source | 13,428,715Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 8,857,174Source | -5,104,273Source | 698,989Source | 1,075,771Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 13,596,600Source | 4,739,426Source | 9,843,699Source | — |
| Additional Financial Items | ||||
| Inventory Write-downUSD | — | — | — | 30,000Source |
| Investment Income, InterestUSD | 353,313Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -5,352,194Source | -7,792,295Source | -8,224,130Source | -8,537,952Source |
| Nonoperating Income (Expense)USD | — | -361,404Source | -437,993Source | -386,305Source |
| Operating ExpensesUSD | 15,453,552Source | 12,611,521Source | 10,294,782Source | 9,769,723Source |
| Operating Lease, ExpenseUSD | — | — | — | 136,000Source |
| Other Nonoperating Income (Expense)USD | -148,057Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | 13,070,154Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | 45,454Source |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | 10,249,415Source | 5,180,630Source | 2,508,645Source | 1,618,076Source |
| Selling, General and Administrative ExpenseUSD | 15,080,699Source | 12,227,735Source | 9,623,599Source | 8,851,129Source |
| Operating Income (Loss)USD | -5,204,137Source | -7,430,891Source | -7,786,137Source | -8,151,647Source |
| Other Nonoperating Income (Expense)USD | -148,057Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -5,352,194Source | -7,792,295Source | -8,224,130Source | -8,537,952Source |
| Earnings Per Share, BasicUSD per share | -2.81Source | -2.33Source | -2.62Source | — |
| Earnings Per Share, DilutedUSD per share | -2.81Source | -2.33Source | -2.62Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 1,905,072Source | 3,343,070Source | 3,143,626Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 1,905,072Source | 3,343,070Source | 3,143,626Source | — |
| Additional Financial Items | ||||
| Interest ExpenseUSD | 501,370Source | 500,000Source | 500,000Source | 500,050Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | 138,596Source | 62,007Source | 8,615Source |
| Investment Income, InterestUSD | 353,313Source | — | — | — |
| Nonoperating Income (Expense)USD | — | -361,404Source | -437,993Source | -386,305Source |
| Operating ExpensesUSD | 15,453,552Source | 12,611,521Source | 10,294,782Source | 9,769,723Source |
| Operating Lease, ExpenseUSD | — | — | — | 136,000Source |